PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A coloclyster of red peony root granules helped alleviate clinical symptoms and shortened the course of MSAP, including shorter remission time of fever [PMID:32774431].
Red peony root decoction reduced the duration of abdominal tenderness, fever, and abdominal distension compared to rhubarb treatment [PMID:18559232].
Xuebijing injection (containing red peony) is used as adjuvant therapy for sepsis and associated complications [PMID:41194878, PMID:29860133].
Xuebijing injection (containing red peony) demonstrated protective effects in a murine model by inhibiting cell apoptosis and inflammation through the Hippo pathway [PMID:40529898].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32237400 (2019) — [Textual research on Chinese herbaceous peony in Chinese classical prescriptions]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- 2.PMID: 30144752 (2018) — Advancement in the chemical analysis of Paeoniae Radix (Shaoyao). · Journal of pharmaceutical and biomedical analysis
- 3.PMID: 38133706 (2024) — Comprehensive study on genetic and chemical diversity of Asian medicinal plants, aimed at sustainable use and standardization of traditional crude drugs. · Journal of natural medicines
- 4.PMID: 35863612 (2022) — Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis). · Journal of ethnopharmacology
- 5.PMID: 25151277